Showing results (11-20 of 266) with videos related to
Sort By:
Pageof 27
European Journal of Immunology|December 8, 1998
Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificityI Khalil-Daher, F Boisgérault, J P Feugeas, et al.Bone Marrow Transplantation|August 26, 1998
Characterisation of the roles of CD95 and CD95 ligand in cord bloodB Drénou, C Choqueux, A El Ghalbzouri, et al.The Journal of Clinical Investigation|December 15, 1996
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathiesF Boisgérault, V Tieng, M C Stolzenberg, et al.Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathyF Boisgerault, I Khalil, V Tieng, et al.Bone Marrow Transplantation|August 26, 1998
Effects of superantigenic stimulation on the cord blood alphabeta T cell repertoireA Toubert, C Douay, N Chalumeau, et al.Infection and Immunity|August 26, 1998
Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneriF Boisgérault, J Mounier, V Tieng, et al.Tissue Antigens|June 14, 2000
A novel HLA-B null allele (B*4022N) generated by a nonsense codon in the alpha1 domainR Tamouza, K Sadki, V Schaeffer, et al.Leukemia|September 3, 2004
Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylateN Boissel, P Rousselot, E Raffoux, et al.Tissue Antigens|November 7, 2001
A new HLA-Cw allele (Cw*1510), identified in a French Caucasian individualR Tamouza, V Schaeffer, F Marzais, et al.Tissue Antigens|July 8, 1999
Characterization of a novel HLA-Cw*04 variant in a Laotian family: HLA-Cw*0406E Carbonnelle, J C Poirier, C Fortier, et al.Pageof 27